Upregulation of PP2Ac predicts poor prognosis and contributes to aggressiveness in hepatocellular carcinoma

References

• Venook AP, Papandreou C, Furuse J, de Guevara LL: The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 2010; 15 Suppl 4:5-13; PMID:21115576; http://dx.doi.org/10.1634/theoncologist.2010-S4-05
   PubMed Web of Science ®Google Scholar
• Nagaoki Y, Hyogo H, Aikata H, Tanaka M, Naeshiro N, Nakahara T, Honda Y, Miyaki D, Kawaoka T, Takaki S, et al. Recent trend of clinical features in patients with hepatocellular carcinoma. Hepatol Res 2012; 42:368-75; PMID:22151896; http://dx.doi.org/10.1111/j.1872-034X.2011.00929.x
   PubMed Web of Science ®Google Scholar
• Lau CC, Sun T, Ching AK, He M, Li JW, Wong AM, Co NN, Chan AW, Li PS, Lung RW, et al. Viral-human chimeric transcript predisposes risk to liver cancer development and progression. Cancer Cell 2014; 25:335-49; PMID:24582836; http://dx.doi.org/10.1016/j.ccr.2014.01.030
   PubMed Web of Science ®Google Scholar
• Ng SA, Lee C: Hepatitis B virus X gene and hepatocarcinogenesis. J Gastroenterol 2011; 46:974-90; PMID:21647825; http://dx.doi.org/10.1007/s00535-011-0415-9
   PubMed Web of Science ®Google Scholar
• Quetier I, Brezillon N, Revaud J, Ahodantin J, DaSilva L, Soussan P, Kremsdorf D: C-terminal-truncated hepatitis B virus X protein enhances the development of diethylnitrosamine-induced hepatocellular carcinogenesis. J Gen Virol 2015; 96:614-25; PMID:25519169; http://dx.doi.org/10.1099/vir.0.070680-0
   PubMed Web of Science ®Google Scholar
• Liu X, Zhang S, Lin J, Zhang S, Feitelson MA, Gao H, Zhu M: Hepatitis B virus X protein mutants exhibit distinct biological activities in hepatoma Huh7 cells. Biochem Biophys Res Commun 2008; 373:643-7; PMID:18602370; http://dx.doi.org/10.1016/j.bbrc.2008.06.087
   PubMed Web of Science ®Google Scholar
• Liu X, Wang L, Zhang S, Lin J, Zhang S, Feitelson MA, Gao H, Zhu M: Mutations in the C-terminus of the X protein of hepatitis B virus regulate Wnt-5a expression in hepatoma Huh7 cells: cDNA microarray and proteomic analyses. Carcinogenesis 2008; 29:1207-14; PMID:18477650; http://dx.doi.org/10.1093/carcin/bgn111
   PubMed Web of Science ®Google Scholar
• Seshacharyulu P, Pandey P, Datta K, Batra SK: Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer. Cancer Lett 2013; 335:9-18; PMID:23454242; http://dx.doi.org/10.1016/j.canlet.2013.02.036
   PubMed Web of Science ®Google Scholar
• Chien W, Sun QY, Lee KL, Ding LW, Wuensche P, Torres-Fernandez LA, Tan SZ, Tokatly I, Zaiden N, Poellinger L, et al. Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancer. Mol Oncol 2015; 9:889-905; PMID:25637283; http://dx.doi.org/10.1016/j.molonc.2015.01.002
   PubMed Web of Science ®Google Scholar
• Rincon R, Cristobal I, Zazo S, Arpi O, Menendez S, Manso R, Lluch A, Eroles P, Rovira A, Albanell J, et al. PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects. Oncotarget 2015; 6:4299-314; PMID:25726524; http://dx.doi.org/10.18632/oncotarget.3012
   PubMed Web of Science ®Google Scholar
• Zhu DW, Yuan YX, Qiao JK, Yu C, Yang X, Wang LZ, Zhang ZY, Zhong LP: Enhanced anticancer activity of a protein phosphatase 2A inhibitor on chemotherapy and radiation in head and neck squamous cell carcinoma. Cancer Lett 2015; 356:773-80; PMID:25449438; http://dx.doi.org/10.1016/j.canlet.2014.10.024
   PubMed Web of Science ®Google Scholar
• Lv P, Wang Y, Ma J, Wang Z, Li JL, Hong CS, Zhuang Z, Zeng YX: Inhibition of protein phosphatase 2A with a small molecule LB100 radiosensitizes nasopharyngeal carcinoma xenografts by inducing mitotic catastrophe and blocking DNA damage repair. Oncotarget 2014; 5:7512-24; PMID:25245035; http://dx.doi.org/10.18632/oncotarget.2258
   PubMed Web of Science ®Google Scholar
• Duong FH, Dill MT, Matter MS, Makowska Z, Calabrese D, Dietsche T, Ketterer S, Terracciano L, Heim MH: Protein phosphatase 2A promotes hepatocellular carcinogenesis in the diethylnitrosamine mouse model through inhibition of p53. Carcinogenesis 2014; 35:114-22; PMID:23901063; http://dx.doi.org/10.1093/carcin/bgt258
   PubMed Web of Science ®Google Scholar
• Duong FH, Filipowicz M, Tripodi M, La Monica N, Heim MH: Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A. Gastroenterology 2004; 126:263-77; PMID:14699505; http://dx.doi.org/10.1053/j.gastro.2003.10.076
   PubMed Web of Science ®Google Scholar
• Duong FH, Christen V, Lin S, Heim MH: Hepatitis C virus-induced up-regulation of protein phosphatase 2A inhibits histone modification and DNA damage repair. Hepatology 2010; 51:741-51; PMID:20043320; http://dx.doi.org/10.1002/hep.23388
   PubMed Web of Science ®Google Scholar
• Guerrieri F, Belloni L, Pediconi N, Levrero M: Molecular mechanisms of HBV-associated hepatocarcinogenesis. Semin Liver Dis 2013; 33:147-56; PMID:23749671; http://dx.doi.org/10.1055/s-0033-1345721
   PubMed Web of Science ®Google Scholar
• Bhardwaj A, Singh S, Srivastava SK, Arora S, Hyde SJ, Andrews J, Grizzle WE, Singh AP: Restoration of PPP2CA expression reverses epithelial-to-mesenchymal transition and suppresses prostate tumour growth and metastasis in an orthotopic mouse model. Br J Cancer 2014; 110:2000-10; PMID:24642616; http://dx.doi.org/10.1038/bjc.2014.141
   PubMed Web of Science ®Google Scholar
• Cristobal I, Garcia-Orti L, Cirauqui C, Alonso MM, Calasanz MJ, Odero MD: PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect. Leukemia 2011; 25:606-14; PMID:21233840; http://dx.doi.org/10.1038/leu.2010.294
   PubMed Web of Science ®Google Scholar
• Roberts KG, Smith AM, McDougall F, Carpenter H, Horan M, Neviani P, Powell JA, Thomas D, Guthridge MA, Perrotti D, et al. Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT+ cancers. Cancer Res 2010; 70:5438-47; PMID:20551067; http://dx.doi.org/10.1158/0008-5472.CAN-09-2544
   PubMed Web of Science ®Google Scholar
• Kang HS, Choi I: Protein phosphatase 2A modulates the proliferation of human multiple myeloma cells via regulation of the production of reactive oxygen intermediates and anti-apoptotic factors. Cell Immunol 2001; 213:34-44; PMID:11747354; http://dx.doi.org/10.1006/cimm.2001.1861
   PubMed Web of Science ®Google Scholar
• Muzio G, Maggiora M, Oraldi M, Trombetta A, Canuto RA: PPARalpha and PP2A are involved in the proapoptotic effect of conjugated linoleic acid on human hepatoma cell line SK-HEP-1. Int J Cancer 2007; 121:2395-401; PMID:17691108; http://dx.doi.org/10.1002/ijc.23004
   PubMed Web of Science ®Google Scholar
• Bai X, Zhi X, Zhang Q, Liang F, Chen W, Liang C, Hu Q, Sun X, Zhuang Z, Liang T: Inhibition of protein phosphatase 2A sensitizes pancreatic cancer to chemotherapy by increasing drug perfusion via HIF-1alpha-VEGF mediated angiogenesis. Cancer Lett 2014; 355:281-7; PMID:25304380; http://dx.doi.org/10.1016/j.canlet.2014.09.048
   PubMed Web of Science ®Google Scholar
• Janssens V, Rebollo A: The role and therapeutic potential of Ser/Thr phosphatase PP2A in apoptotic signalling networks in human cancer cells. Curr Mol Med 2012; 12:268-87; PMID:22300139; http://dx.doi.org/10.2174/156652412799218930
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhao J, Zhang W, Gan J, Hu C, Huang G, Zhang Y: lncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer. Sci Rep 2015; 5:10159; PMID:25959498; http://dx.doi.org/10.1038/srep10159
   PubMed Web of Science ®Google Scholar
• Siriwardana G, Seligman PA: Iron depletion results in Src kinase inhibition with associated cell cycle arrest in neuroblastoma cells. Physiol Rep 2015; 3:1-10; PMID:25825542; http://dx.doi.org/10.14814/phy2.12341
   PubMedGoogle Scholar
• Schweyer S, Bachem A, Bremmer F, Steinfelder HJ, Soruri A, Wagner W, Pottek T, Thelen P, Hopker WW, Radzun HJ, et al. Expression and function of protein phosphatase PP2A in malignant testicular germ cell tumours. J Pathol 2007; 213:72-81; PMID:17590861; http://dx.doi.org/10.1002/path.2203
   PubMed Web of Science ®Google Scholar
• Bi L, Liu X, Wang C, Cao Y, Mao R, Li P, Geng M: Wnt5a involved in regulation of the biological behavior of hepatocellular carcinoma. Int J Clin Exp Pathol 2014; 7:987-95; PMID:24696716
   PubMed Web of Science ®Google Scholar
• Zou C, Chen J, Chen K, Wang S, Cao Y, Zhang J, Sheng Y, Huang A, Tang H: Functional analysis of miR-181a and Fas involved in hepatitis B virus-related hepatocellular carcinoma pathogenesis. Exp Cell Res 2015; 331:352-61; PMID:25449696; http://dx.doi.org/10.1016/j.yexcr.2014.11.007
   PubMed Web of Science ®Google Scholar
• Fernando J, Sancho P, Fernandez-Rodriguez CM, Lledo JL, Caja L, Campbell JS, Fausto N, Fabregat I: Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli. J Cell Physiol 2012; 227:1319-25; PMID:21604268; http://dx.doi.org/10.1002/jcp.22843
   PubMed Web of Science ®Google Scholar
• Cheng Q, Yuan F, Lu F, Zhang B, Chen T, Chen X, Cheng Y, Li N, Ma L, Tong T: CSIG promotes hepatocellular carcinoma proliferation by activating c-MYC expression. Oncotarget 2015; 6:4733-44; PMID:25749381; http://dx.doi.org/10.18632/oncotarget.2900
   PubMed Web of Science ®Google Scholar
• Fang Z, Zhou L, Jiang S, Cao L, Yu L: UNC50 prompts G1/S transition and proliferation in HCC by regulation of epidermal growth factor receptor trafficking. PLoS One 2015; 10:e0119338; PMID:25738771; http://dx.doi.org/10.1371/journal.pone.0119338
   PubMedGoogle Scholar
• Zhang L, Wang JN, Tang JM, Kong X, Yang JY, Zheng F, Guo LY, Huang YZ, Zhang L, Tian L, et al. VEGF is essential for the growth and migration of human hepatocellular carcinoma cells. Mol Biol Rep 2012; 39:5085-93; PMID:22161247; http://dx.doi.org/10.1007/s11033-011-1304-2
   PubMed Web of Science ®Google Scholar
• Yu LX, Zhou L, Li M, Li ZW, Wang DS, Zhang SG: The Notch1/cyclooxygenase-2/Snail/E-cadherin pathway is associated with hypoxia-induced hepatocellular carcinoma cell invasion and migration. Oncol Rep 2013; 29:362-70; PMID:23124652; http://dx.doi.org/10.3892/or.2012.2103
   PubMed Web of Science ®Google Scholar
• Liu AW, Cai J, Zhao XL, Jiang TH, He TF, Fu HQ, Zhu MH, Zhang SH: ShRNA-targeted MAP4K4 inhibits hepatocellular carcinoma growth. Clin Cancer Res 2011; 17:710-20; PMID:21196414; http://dx.doi.org/10.1158/1078-0432.CCR-10-0331
   PubMed Web of Science ®Google Scholar
• Barr RK, Lynn HE, Moretti PA, Khew-Goodall Y, Pitson SM: Deactivation of sphingosine kinase 1 by protein phosphatase 2A. J Biol Chem 2008; 283:34994-5002; PMID:18852266; http://dx.doi.org/10.1074/jbc.M804658200
   PubMed Web of Science ®Google Scholar
• Zhu Z, Luo Z, Li Y, Ni C, Li H, Zhu M: Human inhibitor of growth 1 inhibits hepatoma cell growth and influences p53 stability in a variant-dependent manner. Hepatology 2009; 49:504-12; PMID:19085961; http://dx.doi.org/10.1002/hep.22675
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-8; PMID:11846609; http://dx.doi.org/10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar